At 13.9% CAGR Microsurgery Robot Market to hit USD 1.7 bn by 2024

The Microsurgery robot Market to exceed USD 1.7 billion by 2024; according to a new research report by Global Market Insights. Technological advancements in microsurgery robot allowing effective treatment of various chronic disorders is forecasted to boost market growth during the foreseeable future. Advances such as miniaturization of robotic arms aid to reduce complications and undesirable effects post-surgery will foster business growth. For instance, in October 2017, surgeons from Maastricht University in Netherlands carried out microsurgery for suturing blood vessels of 0.3 mm for treatment of lymphedema. Such advancements will propel microsurgery robot industry growth during the projected timeframe.

Request Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/2814

Increasing number of government and private funding aimed at development of advanced robotic in surgical procedures will potentially spur market growth. As a result, there are numerous surgeries performed in hospitals, clinics and ambulatory surgical centers with robotic assistance. For instance, American Society for Cataract and Refractive Surgery provide research funding for development of surgical robot that can be used for colorectal surgery. High demand for microsurgical robot in healthcare facilities coupled with various funding for advancement of microsurgery robot are set to offer lucrative growth over the forecast timeframe.

Hospitals and clinics segment held largest revenue share of 50.7% in 2017. The segmental growth is attributable to growing burden of chronic diseases on healthcare industry. Multi-speciality hospitals offer advanced therapeutic solutions to patients, thereby improving patient outcomes. Affordability of hospitals to buy technologically advanced robotic systems and increasing adoption of minimally invasive surgical procedures will increase demand for microsurgery robot in forthcoming period.

Ambulatory surgical centers segment will grow with a remarkable rate of 14.5% during the forecast timeframe. High growth rate is credited to cost-effective treatment options provided by ambulatory surgical centers. Reduction in length of stay in ambulatory surgical centers is major factor propelling segmental growth. As there is high adoption rate of surgical robots in ambulatory surgical centers for providing minimal invasive surgery, segmental growth will be tremendous in the future.

Urology surgery segment dominated in 2017, with segmental revenue of USD 140.9 million owing to huge applicability of robot-assisted surgeries in urology disorders. Congenital abnormalities of reproductive organs can be treated efficiently by using microsurgical robots. Complex procedures such as pyeloplasty can be managed effectively by use of robotic assistance that offers greater precision than laparoscopic pyeloplasty. Employment of microsurgery robot helps reducing recovery time along with prevention of blood loss. These benefits will facilitate accelerating demand for microsurgery robot in urology disorders in forthcoming years, thereby augmenting segmental growth.

Oncology surgery segment will grow at a momentous rate of 15.7% during the forecast timeframe owing to high pervasiveness of cancer. According to World Health Organization, in 2015, more than 24.6 million people worldwide suffered from cancer. Robotic surgery can be employed for treatment of various cancers such as prostate cancer, colorectal cancer, head and neck cancer. Shorter recovery time and low post-operative complication are few of the advantages offered by robotic-assisted cancer treatment. Such factors will favour segmental growth in recent years.

U.S. microsurgery robot market contributed to the largest revenue of USD 355.1 million in North America in 2017. High per-capita and disposable income will enable patients to opt microsurgical robot for various surgical procedures. According to General Surgery News, in 2015, about 140 thousand robotic general surgeries were performed in U.S. Microsurgical robot is widely used in U.S. due to growing demand for minimally invasive surgical procedures. This will foster regional growth in foreseeable years.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2814

Some of the prominent players involved in microsurgery robots market are Auris Health, Intuitive Surgical, Mazor Robotics, Medrobotics, Medtronic, Smith & Nephew, Stryker, Titan medical, Transenterix and Zimmer Biomet. These firms are adopting strategies initiatives like mergers and acquisitions, geographical expansion and new product launch to reap benefits in microsurgery robots market. For instance, in May 2018, Intuitive Surgical announced its independent operations in India. This will expand the company’s geographic outreach and attract large customer base in emerging markets for long-term growth in future.